(S)-DMT-glycidol-T is a pharmaceutical intermediate used in oligonucleotide synthesis. It features a thymine base linked to a DMT-protected glycidol moiety and contains multiple aromatic rings, ether groups, and a secondary alcohol.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 168332-12-5
2'-O-(2-Methoxyethyl)-5-methyl-uridine
pharmaceutical intermediate for oligonucleotide synthesis
2'-O-(2-Methoxyethyl)adenosine
pharmaceutical intermediate
(3R)-1-benzylpiperidin-3-amine
pharmaceutical intermediate
(S)-3-Amino-1-benzylpiperidine
pharmaceutical intermediate
Tetrahydro-2-furancarboxylic acid
pharmaceutical intermediate
1-[(2R)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-hydroxypropyl]-5-methylpyrimidine-2,4-dione
pharmaceutical intermediate
(S)-GNA-T-phosphoramidite
Pharmaceutical intermediate for GNA synthesis
(S)-GNA-U-phosphoramidite
Phosphoramidite building block for oligonucleotide synthesis
1-[(2S)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-hydroxypropyl]-5-methylpyrimidine-2,4-dione
IUULEBAFSFROKM-DEOSSOPVSA-N
CC1=CN(C(=O)NC1=O)C[C@@H](COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC)O